Altbuch T.,University of Florida |
Conrad B.P.,University of Florida |
Shields E.,RTI Biologics Inc. |
Farmer K.W.,University of Florida
Cell and Tissue Banking | Year: 2013
The purpose of this study was to determine whether the pull-through force of soft-tissue allografts increases over time after being hydrated with saline-soaked sponges. Eighteen aseptic soft-tissue, fresh-frozen anterior tibialis allograft specimens were thawed and sized using standard sizing guides. After sizing, initial pull-through force was measured using an Instron Model 5865 machine. Grafts were randomized to soak in saline sponges for 20, 40, or 60 min. After soaking, pull-through force was again assessed. Pre- and post-soaking pull-through forces were compared using a paired t test. The effect of time on pull-through force was evaluated using an ANOVA and Tukey post hoc test. Two allografts had initial pull-through forces outside the inclusion criteria and were excluded. The average pull-through force for the remaining 16 allografts pre-soaking was 43.0 N and post-soaking was 81.7 N, for an increase of 90 % (P < 0.001). Longer hydration time in the saline soaked sponges was not correlated with higher pull-through force (P = 0.724). Pull-through force post-hydration was not related to the allograft diameter (P = 0.641). Post-hydration, 33 % of grafts that had soaked for 20 min and 40 % of grafts that had soaked for 40 or 60 min required greater than 100 N pull-through force. Our data supports the hypothesis that soft-tissue allografts swell as a result of being stored in saline-soaked sponges, resulting in greater pull-through forces during graft passage. Surgeons should bear in mind that allografts swell when stored in saline-soaked gauze and should size their tunnels accordingly. © 2013 Springer Science+Business Media Dordrecht.
Moore S.T.,RTI Biologics Inc. |
Katz J.M.,Orthocon |
Zhukauskas R.M.,RTI Biologics Inc. |
Hernandez R.M.,RTI Biologics Inc. |
And 6 more authors.
Journal of Biomaterials Applications | Year: 2011
Bone graft substitutes have been developed due to the limited supply and morbidity associated with using autogenous graft material. Allogeneic demineralized bone matrix (DBM) has been used extensively as a clinical graft material because of its inherent osteoinductive and osteoconductive properties. Differential enhancement of these properties may optimize the performance of these products for various orthopedic and craniofacial applications. Commercially available bone paste products consist of formulations that combine DBM with a carrier to facilitate handling and containment. In the present study, we present results of a comprehensive in vitro and in vivo characterization of a 100% human DBM putty product, Puros DBM Putty. Results indicate the DBM particles are completely dispersed in the putty. Data are presented showing the porosity of and cell attachment to Puros DBM Putty, thereby demonstrating the osteoconductive properties of this DBM. Puros DBM Putty was also shown to be osteoinductive in the rat ectopic pouch model. We demonstrate here for the first time that Puros DBM Putty maintains its activity to markedly stimulate or induce bone formation over the entire period of its shelf life. Taken together, these data demonstrate that the 100% human allograft derived Puros DBM Putty could be an effective bone graft substitute. © The Author(s), 2010.
Faleris J.A.,RTI Biologics Inc. |
Hernandez R.M.C.,RTI Biologics Inc. |
Wetzel D.,RTI Biologics Inc. |
Dodds R.,RTI Biologics |
Greenspan D.C.,Spinode Consulting
Hernia | Year: 2011
Purpose: Post-herniation abdominal wall repair can be performed with synthetic or biologic meshes. Synthetics have been associated with complications, so biologics are promising alternatives. The methods used to decellularize biological matrices may affect the extracellular components. This study evaluated the post-implantation biological response of two allogenic acellular dermal matrices (ADMs) in a hernia model. Methods: Testing was conducted with two ADMs from different manufacturers: RTI Biologics (ADM-R) and LifeCell (ADM-L). Samples were evaluated for collagen IV, glycosaminoglycans (GAGs), and elastin before implantation. Samples were also used to repair bilateral full-thickness defects in rat abdominal walls. Pathologist evaluations included explant dimensions, inflammation, neovascularization, mature implant tissue, fibrosis, encapsulation, necrosis, mineralization, adhesions, granulomas, and hemorrhages at four and eight weeks post-implantation. Results: GAG distribution in ADM-R samples was more consistent with native dermis than that in ADM-L samples. Collagen IV was visible in ADM-R, but not in ADM-L. The four-week ADM-R explants showed primarily lymphocytic infiltrates, and less inflammation at eight weeks. The four-week ADM-L explants showed primarily lymphocytic infiltrates, and sustained inflammation at eight weeks. Fibroplasia at four and eight weeks was higher in ADM-L than in ADM-R. Encapsulation, mature connective tissue, and vascular profile scores were comparable between groups. Picrosirius red image analysis showed no significant differences between groups. Conclusions: The post-processing matrix characterization and in-vivo response showed notable differences in these ADMs, despite similar allogenic origin. Future investigations into the different matrix composition with regard to fibrosis and inflammation are warranted. © 2010 Springer-Verlag.